spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Healthcare News Roundup: Oncology

 HSMN NewsFeed - 23 Oct 2015
Spectrum Pharmaceuticals Receives Complete Response Letter (CRL) from U.S. Food and Drug Administration (FDA) for EVOMELA(TM) (melphalan) for Injection
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 22 Oct 2015
Merrimack Announces U.S. FDA Approval of ONIVYDE(TM) (irinotecan liposome injection) for the Treatment of Patients with Metastatic Pancreatic Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 Oct 2015
Unum Therapeutics Expands Leadership Team by Appointing Dr. Michael J. Vasconcelles as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Oct 2015
Elekta highlights leading R&D program and reiterates financial ambitions
Devices Oncology Neurosurgery
 HSMN NewsFeed - 19 Oct 2015
AVAX Technologies, Inc. Announces the Appointment of Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Oct 2015
Sorrento Expands its Executive Management Team with Appointment of Dr. Jeffrey Su as Chief Operating Officer to Lead its in-house Bioprocess and Manufacturing Operations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Oct 2015
Virttu Biologics Announces Appointment Of Deirdre Y. Gillespie As Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 Oct 2015
Qfix Announces Launch of kVue(TM) Portrait(TM) Proton Head & Neck Insert for Proton Therapy Treatment
Devices Oncology Product Launch
 HSMN NewsFeed - 16 Oct 2015
Qfix Launches DoseMax(TM) SBRT Solution, a Revolution in Skin-Sparing
Devices Oncology Product Launch
 HSMN NewsFeed - 16 Oct 2015
Qfix Announces Launch of New Portrait(TM) S-Frame Mask for Head and Neck Radiotherapy Treatment
Devices Oncology Product Launch
 HSMN NewsFeed - 15 Oct 2015
Teikoku Pharma USA and Eagle Pharmaceuticals Enter into License Agreement for Docetaxel, Non-Alcohol Formula
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 15 Oct 2015
GenomeDx Biosciences Adds Tina Nova and Craig Johnson to Board of Directors
Diagnostics Personalized Medicine Oncology Personnel
 HSMN NewsFeed - 15 Oct 2015
Kelly Londy Named Chief Operating Officer Of Accuray
Devices Oncology Personnel
 HSMN NewsFeed - 14 Oct 2015
MyoKardia Appoints Renowned Cardiovascular Medicine Expert Eric Topol, M.D., to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 Oct 2015
Eclipse(TM) Treatment Planning Software from Varian Now Offers Robust Optimization and Proton Therapy Dose Calculation Tools
Devices Oncology FDA Product Launch
 HSMN NewsFeed - 14 Oct 2015
Galera Therapeutics Raises $37 Million in Series B Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 14 Oct 2015
Kura Oncology Appoints Thomas Malley to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Oct 2015
Installation Completed for Elekta MRI-guided linear Accelerator at MD Anderson Cancer Center
Devices Oncology
 HSMN NewsFeed - 12 Oct 2015
Uptake Medical Announces First-in-Human Lung Cancer Tumor Ablation Using Intervapor(R) Targeted Vapor Therapy
Devices Oncology
 HSMN NewsFeed - 12 Oct 2015
Varian Medical Systems Receives CE Mark for its Latest ProBeam(R) Proton Therapy System
Devices Oncology Regulatory
 HSMN NewsFeed - 12 Oct 2015
Fate Therapeutics Announces Leadership Transition
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Oct 2015
Seven US Medical Centers to Acquire Elekta's New Leksell Gamma Knife Icon Brain Radiosurgery System
Devices Neurosurgery Oncology
 HSMN NewsFeed - 8 Oct 2015
Lilly Receives FDA Breakthrough Therapy Designation for Abemaciclib - a CDK 4 and 6 Inhibitor - in Advanced Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 6 Oct 2015
Exelixis Announces Positive Overall Survival Results from Phase 3 Pivotal Trial of Cobimetinib in Combination with Vemurafenib in Patients with BRAF V600 Mutation-Positive Advanced Melanoma
Biopharmaceuticals Oncology Dermatology
 HSMN NewsFeed - 5 Oct 2015
Novocure Announces CE Mark and First Patient Use of Second Generation Optune System
Devices Oncology Regulatory
 HSMN NewsFeed - 2 Oct 2015
RayStation(R) Will Be Extended to Include Treatment Planning for the TomoTherapy(R) and CyberKnife(R) Systems
Devices Oncology
 HSMN NewsFeed - 1 Oct 2015
Neon Therapeutics Launches with $55 Million Series A to Develop Neoantigen-based Cancer Immunotherapies
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 1 Oct 2015
Bristol-Myers Squibb Receives Approval from the U.S. Food and Drug Administration for the Opdivo (nivolumab) + Yervoy (ipilimumab) Regimen in BRAF V600 Wild-Type Unresectable or Metastatic Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 30 Sep 2015
Blueprint Medicines Receives FDA Orphan Drug Designation for Novel Drug Candidate for Treatment of Hepatocellular Carcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 30 Sep 2015
J. Robert Paulson and Jeffrey Mathiesen Appointed to Sun BioPharma Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 29 Sep 2015
Corvus Pharmaceuticals Completes $75 Million Series B Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 29 Sep 2015
Elekta States That Varian Claims Lack Merit
Devices Oncology Litigation
 HSMN NewsFeed - 25 Sep 2015
Merck and Pfizer Announce FDA Orphan Drug Designation for Investigational Immunotherapy Avelumab in Merkel Cell Carcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 25 Sep 2015
Surefire Medical Launches Advanced Precision Direct-To-Tumor Infusion System At CIRSE
Devices Interventional Oncology Product Launch
 HSMN NewsFeed - 25 Sep 2015
Celgene’s VIDAZA(R) (Azacitidine for Injection) Receives Positive CHMP Opinion as New Treatment for Elderly Patients with Acute Myeloid Leukaemia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 24 Sep 2015
Cerulean Appoints David R. Walt, Ph.D. to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 24 Sep 2015
Replimune Ltd Raises $30 Million Series A Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 21 Sep 2015
Deciphera Pharmaceuticals Announces $75 Million Series B Financing to Advance Novel Oncology Pipeline
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 18 Sep 2015
Infinity Expands Pipeline with Addition of IPI-549, an Immuno-Oncology Development Candidate for the Treatment of Solid Tumors
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 17 Sep 2015
Ignyta Appoints Igor Bilinsky as General Manager, Immuno-Oncology and Senior Vice President, Special Operations
Personalized Medicine Oncology Personnel
 HSMN NewsFeed - 16 Sep 2015
Tokai Pharmaceuticals Augments Commercialization Capabilities through Appointment of Lisa Taylor as Senior Vice President, Commercial Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Sep 2015
Molecular Response Appoints the Former Head of Translational Medicine Oncology at MedImmune/AstraZeneca, Brett Hall, Ph.D., as Chief Executive Officer
Diagnostics Personnel
 HSMN NewsFeed - 15 Sep 2015
Jounce Therapeutics Appoints Kim Drapkin, CPA as Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 Sep 2015
iCAD Announces Appointment of Two Vice Presidents to Lead Cancer Detection Sales and Marketing Teams
Devices Oncology Personnel
 HSMN NewsFeed - 10 Sep 2015
Lori Kunkel, M.D., Joins Tocagen's Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 Sep 2015
Metamark Genetics Appoints Kenneth E. Weg as President and Chief Executive Officer
Diagnostics Oncology Personnel
 HSMN NewsFeed - 9 Sep 2015
Synta Names Alan C. Rigby, Ph.D. Chief Scientific Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Sep 2015
ADC Therapeutics Secures $80m Financing to Progress Its Pipeline of Antibody Drug Conjugate Therapeutics in Oncology
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 1 Sep 2015
Surefire Medical Receives FDA Clearance for Precision Direct-to-Tumor Embolization Device
Devices Drug Delivery Interventional Oncology FDA
Older Oncology stories   Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!